000 | 01789 a2200529 4500 | ||
---|---|---|---|
005 | 20250515165447.0 | ||
264 | 0 | _c20090925 | |
008 | 200909s 0 0 eng d | ||
022 | _a1029-2403 | ||
024 | 7 |
_a10.1080/10428190902789181 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHayun, Rami | |
245 | 0 | 0 |
_aRapamycin and curcumin induce apoptosis in primary resting B chronic lymphocytic leukemia cells. _h[electronic resource] |
260 |
_bLeukemia & lymphoma _cApr 2009 |
||
300 |
_a625-32 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
650 | 0 | 4 |
_aCaspase 7 _xmetabolism |
650 | 0 | 4 |
_aCaspase 9 _xmetabolism |
650 | 0 | 4 |
_aCurcumin _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xblood |
650 | 0 | 4 |
_aLeukocytes, Mononuclear _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
650 | 0 | 4 |
_aSirolimus _xpharmacology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_abcl-2-Associated X Protein _xmetabolism |
700 | 1 | _aOkun, Eitan | |
700 | 1 | _aBerrebi, Alain | |
700 | 1 | _aShvidel, Lev | |
700 | 1 | _aBassous, Lucette | |
700 | 1 | _aSredni, Benjamin | |
700 | 1 | _aNir, Uri | |
773 | 0 |
_tLeukemia & lymphoma _gvol. 50 _gno. 4 _gp. 625-32 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/10428190902789181 _zAvailable from publisher's website |
999 |
_c18805375 _d18805375 |